Evidence map›Paper›PMID 27693373›Full record

ArticleActa tropica2016

Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis.

Eva Iniguez, Armando Varela-Ramirez, Alberto Martínez, Caresse L Torres, Roberto A Sánchez-Delgado, Rosa A Maldonado

Abstract read
In one paragraph

Article in Acta tropica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Ruthenium (II) complex cis-[RuScientific reports · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eva IniguezBorder Biomedical Research Center, Bioscience Research Building, Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, USA.
Armando Varela-RamirezBorder Biomedical Research Center, Bioscience Research Building, Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, USA.
Alberto MartínezChemistry Department, New York City College of Technology, The City University of New York, Brooklyn, NY, USA. Electronic address: amartinez@CityTech.Cuny.Edu.
Caresse L TorresBorder Biomedical Research Center, Bioscience Research Building, Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, USA.
Roberto A Sánchez-DelgadoChemistry Department, Brooklyn College and The Graduate Center, The City University of New York, Brooklyn, NY, USA.
Rosa A MaldonadoBorder Biomedical Research Center, Bioscience Research Building, Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, USA. Electronic address: ramaldonado@utep.edu.

Funding

TOXICOLOGY PROJECTG12RR008124 · NCRR · UNIVERSITY OF TEXAS EL PASO · PI WALSH, ELIZABETH J · 1992 to 2011
$20.8M
TCCG12MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI KIRKEN, ROBERT A. · 2012 to 2018
$19.4M
RISE Scholars Program at UTEPR25GM069621 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI AGUILERA, RENATO J · 2004 to 2021
$11.2M
Ruthenium-based antimalarial agentsSC1GM089558 · NIGMS · BROOKLYN COLLEGE · PI SANCHEZ-DELGADO, ROBERTO A · 2010 to 2013
$1.2M
NCRR NIH HHS G12 RR008124NIGMS NIH HHS R25 GM069621NIGMS NIH HHS SC1 GM089558NIMHD NIH HHS G12 MD007592
6 · The paper itself

Abstract

In previous studies we reported a novel series of organometallic compounds, Ru

Indexed as

AnimalsClotrimazoleDrug CombinationsFemaleLeishmania majorLeishmaniasis, CutaneousMiceMice, Inbred BALB COrganometallic CompoundsRutheniumClotrimazoleDrug CombinationsOrganometallic CompoundsRutheniumApoptosisCutaneous leishmaniasisDrug discoveryLeishmania majorParasitesRuthenium-clotrimazole complex

Identifiers

PMID27693373
PMCPMC5108180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.